Table 4.
Group | EMND Activity nmol/min/mg | AH Activity nmol/min/mg |
---|---|---|
Control | 0.566 ± 0.018 | 0.492 ± 0.028 |
ERFE | 0.439 ± 0.034 * | 0.422 ± 0.009 * |
DF sodium | 0.646 ± 0.012 * | 0.549 ± 0.019 * |
ERFE + DF | 0.462 ± 0.009 *+ | 0.448 ± 0.024 *+ |
* p < 0.05 vs. control group; + p < 0.05 vs. DF-treated group.